We examined the transcriptomes of CLL cells from patients with ROR1Lo CLL cells (N = 12) versus those with ROR1Hi CLL (N = 12) for their relative expression of ERK1/2 and NF-κB target genes [19, 21, 39]. This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.